Company Inotiv, Inc.

Equities

NOTV

US45783Q1004

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
8.95 USD -1.97% Intraday chart for Inotiv, Inc. +17.30% +143.87%

Business Summary

Inotiv, Inc. is an international contract research company that is providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Its DSA segment supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Its RMS segment offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Number of employees: 2,005

Sales per Business

USD in Million2022Weight2023Weight Delta
Research Models and Services- Product
60.1 %
341 62.2 % 344 60.1 % +0.99%
Discovery and Safety Assessment- Service
31.5 %
161 29.4 % 180 31.5 % +11.94%
Research Models and Services- Service
7.6 %
42 7.6 % 43 7.6 % +3.82%
Discovery and Safety Assessment- Product
0.8 %
4 0.8 % 5 0.8 % +13.55%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
84.3 %
472 86.2 % 483 84.3 % +2.28%
Netherlands
9.4 %
42 7.7 % 54 9.4 % +27.68%
Other
6.2 %
33 6.1 % 36 6.2 % +6.88%

Managers

Managers TitleAgeSince
Chief Executive Officer 65 19-01-11
Director of Finance/CFO 59 20-03-05
Chief Operating Officer 58 21-02-14
Director/Board Member 58 18-07-01
General Counsel 47 23-10-22
Comptroller/Controller/Auditor 37 21-07-11
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Corporate Officer/Principal - -
Sales & Marketing - 21-11-04

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 17-07-31
Director/Board Member 68 23-01-23
Chairman 70 17-06-13
Director/Board Member 62 23-10-15
Director/Board Member 58 18-07-01
Chief Executive Officer 65 19-01-11
Director/Board Member 59 21-11-03

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 25,790,680 20,917,158 ( 81.10 %) 0 81.10 %

Shareholders

NameEquities%Valuation
1,378,280 5.344 % 10 M $
Vanguard Global Advisers LLC
4.007 %
1,033,314 4.007 % 8 M $
Balyasny Asset Management LP
3.782 %
975,295 3.782 % 7 M $
662,130 2.567 % 5 M $
349,202 1.354 % 3 M $
Millennium Management LLC
0.9806 %
252,897 0.9806 % 2 M $
BlackRock Institutional Trust Co. NA
0.8244 %
212,625 0.8244 % 2 M $
Geode Capital Management LLC
0.7456 %
192,297 0.7456 % 1 M $
Kentucky Planning Partners LLC
0.6439 %
166,076 0.6439 % 1 M $
Wynnefield Capital, Inc.
0.5816 %
150,000 0.5816 % 1 M $

Company contact information

Inotiv, Inc.

2701 Kent Avenue

47906-1382, West Lafayette

+765 463 4527

http://www.inotivco.com
address Inotiv, Inc.(NOTV)